Abstract
Background
Previous reports suggest that complete tolerance to H2 receptor antagonists (H2RAs) in patients with regular H2RA medication may be due to hypergastrinemia-increased histamine synthesis or upregulation of H2 receptors. As proton pump inhibitors (PPIs) have been reported to induce hypergastrinemia (similar to H2RAs), patients receiving long-term medication with PPIs may show tolerance to preanesthetic H2RA. Therefore, we studied the efficacy of an H2RA, roxatidine, in patients receiving long-term PPI medication.
Methods
Effects of H2RA in 15 surgical patients receiving a regular PPI for more than 4 weeks (PPI+H2RA group) were compared with those in 30 patients not receiving regular PPIs or H2RAs (None+H2RA group and None+None group, n = 15 each). Oral roxatidine was given to both PPI+H2RA and None+H2RA group patients as an anesthetic premedication, while it was not given to None+None group patients. Gastric volume and pH were measured after induction of anesthesia.
Results
Gastric pH and volume (ml) in the PPI+H2RA group (5.79 ± 1.61 and 9.1 ± 16.7, respectively) were both similar to those in the None+H2RA group (5.54 ± 2.20 and 9.7 ± 10.8, respectively) but were significantly higher (gastric pH) and lower (volume) than in the None+None group (2.29 ± 1.84 and 29.3 ± 22.8, respectively, P < 0.01).
Conclusions
These data suggest that long-term PPI medication may not induce a tolerance to H2RAs.
Similar content being viewed by others
References
KP Steinberg (2002) ArticleTitleStress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit Crit Care Med 30 IssueIDSuppl S362–4 Occurrence Handle12072662 Occurrence Handle10.1097/00003246-200206001-00005
K Hirota T Kushikata (2003) ArticleTitlePreanaesthetic H2 antagonists for acid aspiration pneumonia prophylaxis. Is there evidence of tolerance? Br J Anaesth 90 576–9 Occurrence Handle12697583 Occurrence Handle10.1093/bja/aeg065 Occurrence Handle1:STN:280:DC%2BD3s7nvVGjsw%3D%3D
K Hirota M Kudo T Kushikata H Hashimoto A Matsuki (2005) ArticleTitleRegular Use of H2 antagonists reduces preanaesthetic efficacy for acid aspiration pneumonia prophylaxis in anaesthesia patients Can J Anesth 52 166–71 Occurrence Handle15684257
S Hurlimann B Abbühl W Inauen F Halter (1994) ArticleTitleComparison of acid inhibition by either oral high-dose ranitidine or omeprazole Aliment Pharmacol Ther 8 193–201 Occurrence Handle8038351 Occurrence Handle1:CAS:528:DyaK2cXlslShsro%3D Occurrence Handle10.1111/j.1365-2036.1994.tb00278.x
P Netzer C Gaia M Sandoz T Huluk A Gut F Halter et al. (1999) ArticleTitleEffect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours Am J Gastroenterol 94 351–7 Occurrence Handle10022628 Occurrence Handle1:CAS:528:DyaK1MXhtlSjsLo%3D
K Hirota M Kudo H Hashimoto T Kushikata (2005) ArticleTitleEfficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy Anesth Analg 101 1038–41 Occurrence Handle16192516 Occurrence Handle10.1213/01.ane.0000166979.99225.a0 Occurrence Handle1:CAS:528:DC%2BD2MXhtVeqsrrE
GJ Dockray (1999) ArticleTitleTopical review. Gastrin and gastric epithelial physiology J Physiol 518 315–24 Occurrence Handle10381581 Occurrence Handle10.1111/j.1469-7793.1999.0315p.x Occurrence Handle1:CAS:528:DyaK1MXmtVWgsbY%3D
G Qvigstad JS Arnestad E Brenna HL Waldum (1998) ArticleTitleTreatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients Scand J Gastroenterol 33 1244–8 Occurrence Handle9930386 Occurrence Handle10.1080/00365529850172313 Occurrence Handle1:CAS:528:DyaK1MXmvVWntg%3D%3D
S Sanduleanu M Stridsberg D Jonkers W Hameeteman I Biemond G Lundqvist C Lamers et al. (1999) ArticleTitleSerum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case–control study Aliment Pharmacol Ther 13 145–53 Occurrence Handle10102943 Occurrence Handle10.1046/j.1365-2036.1999.00466.x Occurrence Handle1:CAS:528:DyaK1MXitVeksbk%3D
M Robinson (1999) ArticleTitleReview article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia Aliment Pharmacol Ther 13 IssueIDSuppl 5 5–10 Occurrence Handle10555603 Occurrence Handle10.1046/j.1365-2036.1999.00033.x
A el-Nujumi C Williams JE Ardill K Oien KE McColl (1998) ArticleTitleEradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment Gut 42 159–65 Occurrence Handle9536937 Occurrence Handle1:CAS:528:DyaK1cXhvVyht74%3D Occurrence Handle10.1136/gut.42.2.159
KD Bardhan P Cherian AE Bishop JM Polak H Romanska MJ Perry et al. (2001) ArticleTitlePantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies Am J Gastroenterol 96 1767–76 Occurrence Handle11419827 Occurrence Handle10.1111/j.1572-0241.2001.03185.x Occurrence Handle1:CAS:528:DC%2BD3MXltFOgsrc%3D
T Konagaya M Bernsand P Norlen R Hakanson (2001) ArticleTitleMobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats Br J Pharmacol 133 37–42 Occurrence Handle11325792 Occurrence Handle10.1038/sj.bjp.0704037 Occurrence Handle1:CAS:528:DC%2BD3MXjs1aisro%3D
S Nakamura H Watanabe T Yokota H Matsui M Onji K Maeyama (2000) ArticleTitleEffect of rabeprazole on histamine synthesis in enterochromaffin-like cells of mast cell-deficient (Ws/Ws) rats Eur J Pharmacol 394 9–16 Occurrence Handle10771028 Occurrence Handle10.1016/S0014-2999(00)00080-7 Occurrence Handle1:CAS:528:DC%2BD3cXisFKjsL0%3D
T Furuta N Shirai M Sugimoto A Nakamura A Hishida T Ishizaki (2005) ArticleTitleInfluence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies Drug Metab Pharmacokinet 20 153–67 Occurrence Handle15988117 Occurrence Handle10.2133/dmpk.20.153 Occurrence Handle1:CAS:528:DC%2BD2MXoslGmtbo%3D
RB Roberts MA Shirley (1974) ArticleTitleReducing the risk of acid aspiration during cesarean section Anesth Analg 53 859–68 Occurrence Handle4473928 Occurrence Handle1:STN:280:DyaE2M%2Flt1yiug%3D%3D Occurrence Handle10.1213/00000539-197453060-00010
PE Haavik E Søreide B Hofstad PA Steen (1992) ArticleTitleDoes preoperative anxiety influence gastric fluid volume and acidity? Anesth Analg 75 91–4 Occurrence Handle1535490 Occurrence Handle10.1213/00000539-199207000-00017 Occurrence Handle1:STN:280:DyaK38zht1yrtA%3D%3D
C Rosenstock J Møller A Hauberg (2001) ArticleTitleComplaints related to respiratory events in anaesthesia and intensive care medicine from 1994 to 1998 in Denmark Acta Anaesthesiol Scand 45 53–8 Occurrence Handle11152034 Occurrence Handle10.1034/j.1399-6576.2001.450109.x Occurrence Handle1:STN:280:DC%2BD3M7ksF2htA%3D%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hashimoto, H., Kushikata, T., Kudo, M. et al. Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?. J Gastroenterol 42, 275–278 (2007). https://doi.org/10.1007/s00535-006-1946-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-006-1946-3